Tell us about your experiences with weight management. Take our survey!

In Response to COVID-19, Lilly Insulin Value Program Allows $35 Co-Pay

The current COVID-19 pandemic has led many to experience financial and employment strain. Some pharmaceutical companies are taking action to make sure prescription drugs are available and more affordable for those in need. One of these efforts is the Lilly Insulin Value Program. This program is making it possible for some people to fill monthly insulin prescriptions for $35 if they qualify. This includes all Humalog (insulin lispro) formulations.1

Who qualifies for the insulin program $35 co-pay?

People who have commercial insurance and those with no insurance will be able to take advantage of the program. Unfortunately, this means people with government insurance do not qualify. This includes people with Medicaid, Medicare, and Medicare Part D, among others.1

How do I take advantage of this program?

If you are interested and think you may qualify for this program, contact the Lilly Diabetes Solution Center. They can be reached Monday through Friday, 8am to 8pm (EDT). The phone number to reach them at is (833)-808-1234.

If you qualify for a card, it can be sent via email or U.S. mail. Standard mail delivery times may vary, but if you opt for an emailed card, you should receive it within the next day. If you have already worked with this center and have a co-pay card, you do not need to do anything. Current co-pay cards that were issued for amounts greater than $35 have been automatically lowered to the $35 rate.1

What can I do if I still cannot afford my insulin even at a lower co-pay?

If you are still struggling to afford your insulin even after the lowered co-pay, contact the Lilly Diabetes Solution Center at the same number as above. They have staff members answering the line who can help point you in the direction of more support.

These staff members may also be able to suggest additional savings options for other diabetes-related treatments you use. Certain savings options can be combined with the $35 co-pay program to reduce costs even further. Examples of treatments that may be eligible for further savings include Baqsimi (glucagon) nasal powder and Humulin R (insulin normal).1

What can I do if I do not qualify for the program but still need help?

If you have government insurance, like Medicare Part D, and do not qualify for the program, there is still hope. You can contact the Lilly Diabetes Solution Center for suggestions. They may be able to suggest non-branded versions of certain insulin types that are less expensive. Additionally, they may be able to connect you with insulin donation programs for people with lower incomes.1

No matter what your situation, if you are in emergent need of insulin and have no other options, contact the helpline. They will work with you to find a way to get you the treatment you need.

The safety and effectiveness of these insulin products has not changed even though their price has. For more information on your insulin treatment regimen and any side effects or concerns, talk with your doctor. Despite the COVID-19 pandemic, the pharmaceutical company Eli Lilly and Company does not expect there to be shortages on any of their insulin products.1

Note: This article was written on April 9, 2020. Insulin co-pay and coverage may change.

By providing your email address, you are agreeing to our Privacy Policy and Terms of Use.

Join the conversation

Please read our rules before commenting.